Tonix Pharmaceuticals Holding Corp.

TNXP

NASDAQ

Healthcare

Biotechnology

Chatham, NJ, US81 employeestonixpharma.com

$13.91

+0.23(1.65%)

Mkt Cap $186M

$12.03

$61.57

52-Week Range

AI-generated

Tonix Pharmaceuticals Holding Corp.

Revenue breakdown: Zembrace Symtouch (77%), Tosymra (16.9%), Tonmya (6.1%).

$186MMkt Cap

$21MRev TTM

-$195MNI TTM

-1.1xP/E

Latest Earnings

10-K

FY FY2025Mar 11, 2026

Tonix Pharmaceuticals Holding Corp. (TNXP) reported FY 2025 product revenue of $13.1M, up 30% YoY from $10.1M in FY 2024, driven by $1.4M from TONMYA launch in November 2025, $9.3M from Zembrace SymTouch (+9% YoY), and $2.4M from Tosymra (+53% YoY). Cost of sales was $6.6M, yielding a gross margin of 50%, improved from negative gross profit in 2024 due...

Read full analysis View SEC Filing

What Changed Recently

Financial Results

Mar 12, 2026

of this Current Report on Form 8-K, including Exhibit 99.01 attached hereto, shall not be deemed “filed” for purposes of Section 18 of the United States Securit

Financial Results

Feb 2, 2026

Results of Operations and Financial Condition. Tonix Pharmaceuticals Holding Corp. (the “Company”) is disclosing selected preliminary operating results for the

Regulation FD

Mar 30, 2026

of this Current Report on Form 8-K, including Exhibits 99.01, 99.02 and 99.03 attached hereto, shall not be deemed “filed” for purposes of Section 18 of the Uni

Regulation FD

Mar 25, 2026

of this Current Report on Form 8-K shall not be deemed “filed” for purposes of Section 18 of the United States Securities Exchange Act of 1934 (the “Exchange Ac

Regulation FD

Mar 9, 2026

of this Current Report on Form 8-K, including Exhibit 99.01 attached hereto, shall not be deemed “filed” for purposes of Section 18 of the United States Securit

Fundamentals

How The Business Makes Money

Revenue by Segment

Zembrace Symtouch77%($18M)

Tosymra16.9%($4M)

Tonmya6.1%($1M)

Analyst View

Peer Companies

Company	Price	Change	Market Cap	P/E
FBRXForte Biosciences, Inc.	$25.42	+2.25%	$318M	-8.8
AVTXAvalo Therapeutics, Inc.	$17.79	+6.54%	$201M	-2.3
ELTXElicio Therapeutics, Inc.	$10.64	-0.19%	$196M	-4.2
ELDNEledon Pharmaceuticals, I...	$3.04	+1.50%	$183M	-5.1
NKTXNkarta, Inc.	$2.31	+5.71%	$165M	-1.6
FATEFate Therapeutics, Inc.	$1.22	-1.61%	$142M	-1.0
IPHAInnate Pharma S.A.	$1.37	+1.48%	$128M	-2.1
MISTMilestone Pharmaceuticals...	$1.38	+5.34%	$119M	-1.7

Company Profile

CIK0001430306

ISINUS8902608392

CUSIP890260839

Phone862 799 8599

Address26 Main Street, Chatham, NJ, 07928, US

SEC EDGAR